Prostate cancer: 11. Alternative approaches and the future of treatment.
نویسندگان
چکیده
Dr. Trachtenberg is Professor of Surgery and Fleck Tanenbaum Chair of Prostatic Disease, University of Toronto, and Director, The Prostate Centre, Princess Margaret Hospital/The Toronto Hospital, Toronto, Ont. Dr. Crook is Associate Professor of Radiation Oncology, University of Toronto, and Staff Radiation Oncologist, Princess Margaret Hospital, Toronto, Ont. Dr. Tannock is Daniel E. Bergsagel Professor of Medical Oncology, Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Ont. Prostate cancer: 11. Alternative approaches and the future of treatment
منابع مشابه
PI3K and mTOR inhibitor, NVP-BEZ235, is more toxic than X-rays in prostate cancer cells
Background: Radiotherapy and adjuvant androgen deprivation therapy have historically been the first treatment choices for prostate cancer but treatment resistance often limits the capacity to effectively manage the disease. Therefore, alternative therapeutic approaches are needed. Here, the efficacies of radiotherapy and targeting the pro-survival cell signaling components epidermal growth fact...
متن کاملCapacitive Hyperthermia as an Alternative to Brachytherapy in Treatment of Human Prostate Cancer Cell
Introduction: The aim of this study was the evaluation of induced DNA damages of human prostate cancer cells, DU-145, treated with a combination of radiofrequency capacitive hyperthermia (HT) and teletherapy (EBRT) compared to a combination of teletherapy with high dose rate brachytherapy (BR). Materials and Methods: DU-145 cells were cultured as spheroids ...
متن کاملPSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملPreparing Nanoarchaeosome Containing Triptorelin Acetate and Evaluation of Its Cellular Toxic Effect on PC3 Prostate Cancer Cell Line
Background and objectives: Prostate cancer is the second leading cause of mortality among men worldwide, and the eighth cancer-related cause of death in Iran. Male sex hormones (androgens) are the main cause of prostate cancer cells. Triptorelin is considered a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) in the treatment of prostate cancer. This study aimed to evalua...
متن کاملEffects of Copper Nanoparticles in Prostate Normal and Cancer Cell Lines
Background and purpose: In clinical treatment of cancer, improving the efficacy of drugs and targeted drug delivery have always been a fundamental problem requiring more focused solutions. The purpose of this study was to investigate the protective effects of copper nanoparticles in prostate normal and cancer cell lines. Materials and methods: In this experimental study, different concentrati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
دوره 160 4 شماره
صفحات -
تاریخ انتشار 1999